Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alloonc

Alloonc?uq=kzBhZRuG
2013 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Operator of a biotechnology company intended to develop cellular therapeutic invention to cure cancer. The company's product, Mesenkiller uses a molecule which targets cancer cells that is linked with a radioactive particle killing both targeted and the surrounding non targeted cells, enabling cancer patients with efficient and effective therapeutic without having any systemic affects on the body.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • 1396 Milano Drive Unit 3
  • West Sacramento, CA 95691
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Alloonc’s full profile, request a free trial.

Alloonc Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding, request access »

Alloonc Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0

Alloonc Executive Team (1)

Name Title Board
Seat
Contact
Info
Astra Chang Ph.D Founder